| Year |
Citation |
Score |
| 2023 |
Harper J, Hunt T, Choudry M, Kapron AL, Cooney KA, Martin C, Ambrose J, O'Neil B. Clinician interest in clinical decision support for PSA-based prostate cancer screening. Urologic Oncology. PMID 36610816 DOI: 10.1016/j.urolonc.2022.11.015 |
0.356 |
|
| 2022 |
Wei J, Beebe-Dimmer J, Shi Z, Sample C, Yan G, Rifkin AS, Sadeghpour A, Gielzak M, Choi S, Moon D, Zheng SL, Helfand BT, Walsh PC, Xu J, Cooney KA, et al. Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate. PMID 36567534 DOI: 10.1002/pros.24477 |
0.581 |
|
| 2022 |
Trendowski MR, Sample C, Baird T, Sadeghpour A, Moon D, Ruterbusch JJ, Beebe-Dimmer JL, Cooney KA. Germline Variants in DNA Damage Repair Genes and Among Black Patients With Early-Onset Prostate Cancer. Jco Precision Oncology. 6: e2200460. PMID 36446039 DOI: 10.1200/PO.22.00460 |
0.604 |
|
| 2022 |
Shi Z, Zhan J, Wei J, Ladson-Gary S, Wang CH, Hulick PJ, Zheng SL, Cooney KA, Isaacs WB, Helfand BT, Koelsch BL, Xu J. Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations. European Urology Open Science. 45: 23-30. PMID 36353656 DOI: 10.1016/j.euros.2022.09.001 |
0.452 |
|
| 2022 |
Harper JB, Greenberg SE, Hunt TC, Cooney KA, O'Neil BB. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic. The Prostate. PMID 36207779 DOI: 10.1002/pros.24447 |
0.503 |
|
| 2022 |
Xu J, Shi Z, Wei J, Na R, Resurreccion WK, Wang CH, Sample C, Han M, Zheng SL, Cooney KA, Helfand BT, Isaacs WB. KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression. Prostate Cancer and Prostatic Diseases. PMID 35149774 DOI: 10.1038/s41391-021-00466-6 |
0.466 |
|
| 2021 |
Na R, Wei J, Sample CJ, Gielzak M, Choi S, Cooney KA, Rabizadeh D, Walsh PC, Zheng LS, Xu J, Isaacs WB. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients. British Journal of Cancer. PMID 34799695 DOI: 10.1038/s41416-021-01622-4 |
0.58 |
|
| 2021 |
Bancroft EK, Page EC, Brook MN, Thomas S, Taylor N, Pope J, McHugh J, Jones AB, Karlsson Q, Merson S, Ong KR, Hoffman J, Huber C, Maehle L, Grindedal EM, ... ... Cooney KA, et al. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. The Lancet. Oncology. PMID 34678156 DOI: 10.1016/S1470-2045(21)00522-2 |
0.579 |
|
| 2021 |
Shi Z, Lu L, Resurreccion WK, Yang W, Wei J, Wang Q, Engelmann V, Zheng SL, Cooney KA, Isaacs WB, Helfand BT, Lu J, Xu J. Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis. The Prostate. PMID 34674288 DOI: 10.1002/pros.24252 |
0.489 |
|
| 2021 |
Wei J, Yang W, Shi Z, Lu L, Wang Q, Resurreccion WK, Engelmann V, Zheng SL, Hulick PJ, Cooney KA, Isaacs WB, Helfand BT, Lu J, Xu J. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. The Prostate. PMID 34254341 DOI: 10.1002/pros.24195 |
0.552 |
|
| 2021 |
Bhanji Y, Isaacs WB, Xu J, Cooney KA. Prostate Cancer Predisposition. The Urologic Clinics of North America. 48: 283-296. PMID 34210485 DOI: 10.1016/j.ucl.2021.03.001 |
0.545 |
|
| 2020 |
Shi Z, Platz EA, Wei J, Na R, Fantus RJ, Wang CH, Eggener SE, Hulick PJ, Duggan D, Zheng SL, Cooney KA, Isaacs WB, Helfand BT, Xu J. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis. European Urology. PMID 33257031 DOI: 10.1016/j.eururo.2020.11.014 |
0.453 |
|
| 2020 |
Boyle JL, Hahn AW, Kapron AL, Kohlmann W, Greenberg SE, Parnell TJ, Teerlink CC, Maughan BL, Feng BJ, Cannon-Albright L, Agarwal N, Cooney KA. Pathogenic Germline DNA Repair Gene and Mutations in Men With Metastatic Prostate Cancer. Jco Precision Oncology. 4. PMID 32923906 DOI: 10.1200/PO.19.00284 |
0.48 |
|
| 2020 |
Wei J, Shi Z, Na R, Wang CH, Resurreccion WK, Zheng SL, Hulick PJ, Cooney KA, Helfand BT, Isaacs WB, Xu J. Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank. British Journal of Cancer. PMID 32830201 DOI: 10.1038/S41416-020-01036-8 |
0.535 |
|
| 2020 |
Schaid DJ, McDonnell SK, FitzGerald LM, DeRycke L, Fogarty Z, Giles GG, MacInnis RJ, Southey MC, Nguyen-Dumont T, Cancel-Tassin G, Cussenot O, Whittemore AS, Sieh W, Ioannidis NM, Hsieh CL, ... ... Cooney KA, et al. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. European Urology. PMID 32800727 DOI: 10.1016/J.Eururo.2020.07.038 |
0.673 |
|
| 2020 |
Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, et al. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000046. PMID 32516092 DOI: 10.1200/Jco.20.00046 |
0.617 |
|
| 2020 |
Darst BF, Wan P, Sheng X, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Strom SS, Park JY, Zheng W, ... ... Cooney K, et al. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. European Urology. PMID 32409115 DOI: 10.1016/J.Eururo.2020.04.060 |
0.582 |
|
| 2020 |
Oswald N, Lin T, Haaland B, Flynn M, Kawamoto K, Cooney KA, Lowrance W, Hanson HA, O'Neil B. Factors associated with appropriate and low-value PSA testing. Cancer Epidemiology. 66: 101724. PMID 32361642 DOI: 10.1016/J.Canep.2020.101724 |
0.546 |
|
| 2020 |
Smith DC, Daignault-Newton S, Grivas P, Reichert ZR, Hussain M, Cooney KA, Caram M, Alva A, Jacobson J, Yablon C, Mehra R, Escara-Wilke J, Shelley G, Keller ET. Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. PMID 32299729 DOI: 10.1016/J.Clgc.2019.10.019 |
0.566 |
|
| 2020 |
Beebe-Dimmer JL, Kapron AL, Fraser AM, Smith KR, Cooney KA. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902808. PMID 32208047 DOI: 10.1200/Jco.19.02808 |
0.616 |
|
| 2020 |
Greenberg S, Slager S, Neil BO, Cooney K, Maughan B, Stopa N, Venne V, Zickmund S, Colonna S. What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing. The Prostate. 80: 441-450. PMID 32027768 DOI: 10.1002/Pros.23959 |
0.577 |
|
| 2020 |
Wu Y, Yu H, Li S, Wiley K, Zheng SL, LaDuca H, Gielzak M, Na R, Sarver BAJ, Helfand BT, Walsh PC, Lotan TL, Cooney KA, Black MH, Xu J, et al. Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. European Urology Oncology. PMID 31948886 DOI: 10.1016/J.Euo.2019.12.003 |
0.564 |
|
| 2020 |
Boyle J, Cooney KA. DNA repair genes: contributions to prostate cancer predisposition and aggressiveness. The Canadian Journal of Urology. 26: 10-11. PMID 31629416 |
0.574 |
|
| 2020 |
Darst BF, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Park JY, Zheng W, Ostrander EA, Srivastava S, Carpten J, ... ... Cooney KA, et al. Abstract 3517: A germline variant at 8q24 contributes to familial clustering of prostate cancer in men of African ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-3517 |
0.608 |
|
| 2020 |
Wu Y, Yu H, Li S, Wiley K, Zheng S, LaDuca H, Gielzak M, Na R, Sarver B, Helfand* B, Walsh P, Lotan T, Cooney K, Black M, Xu J, et al. PD52-04 RARE GERMLINE PATHOGENIC MUTATIONS OF DNA REPAIR GENES ARE MOST STRONGLY ASSOCIATED WITH GRADE GROUP 5 PROSTATE CANCER The Journal of Urology. 203: e1090-e1091. DOI: 10.1097/Ju.0000000000000954.04 |
0.52 |
|
| 2020 |
Wu Y, Wei J, Shi Z, Fantus R, Zheng S, Cooney K, Isaacs W, Helfand* B, Xu J. PD38-06 WHICH GERMLINE GENES SHOULD BE TESTED FOR ASSESSING PROSTATE CANCER RISK? RESULTS FROM A LARGE POPULATION OF UNSELECTED CASES AND CONTROLS FROM UK BIOBANK The Journal of Urology. 203: e803. DOI: 10.1097/Ju.0000000000000917.06 |
0.529 |
|
| 2019 |
Isaacs WB, Cooney KA, Xu J. Updated insights into genetic contribution to prostate cancer predisposition: focus on HOXB13. The Canadian Journal of Urology. 26: 12-13. PMID 31629417 |
0.621 |
|
| 2019 |
Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Bolton A, Schwartz K, Schwartz AG, Heath E. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation. Cancer Medicine. PMID 31094098 DOI: 10.1002/Cam4.2092 |
0.616 |
|
| 2019 |
Beebe-Dimmer JL, Cooney KA. Mitochondrial alterations may underlie race-specific differences in cancer risk and outcome. The Journal of Clinical Investigation. 130. PMID 31063989 DOI: 10.1172/Jci128707 |
0.387 |
|
| 2019 |
Greenberg S, O'Neil B, Cooney KA, Pappas LM, Tward JD. Clinical characteristics of men with prostate cancer and evaluation of NCCN prostate cancer guidelines on germline genetic testing outcomes. Journal of Clinical Oncology. 37: 252-252. DOI: 10.1200/Jco.2019.37.7_Suppl.252 |
0.686 |
|
| 2019 |
Mara A, Zhu J, Wu Y, Callis T, Yang S, Esplin ED, Nussbaum RL, Zhang T, McNamara MA, Harrison MR, George DJ, Cooney KA, Armstrong AJ. Prevalence of pathogenic germline variants in DNA repair by race, age, and ethnicity in men with prostate cancer. Journal of Clinical Oncology. 37: 5062-5062. DOI: 10.1200/Jco.2019.37.15_Suppl.5062 |
0.599 |
|
| 2019 |
Beebe-Dimmer JL, Kapron A, Fraser AM, Smith KR, Cooney KA. Relative risks of prostate cancer associated with different family cancer histories. Journal of Clinical Oncology. 37: 1505-1505. DOI: 10.1200/Jco.2019.37.15_Suppl.1505 |
0.643 |
|
| 2018 |
O'Neil B, Martin C, Kapron A, Flynn M, Kawamoto K, Cooney KA. Defining low-value PSA testing in a large retrospective cohort: Finding common ground between discordant guidelines. Cancer Epidemiology. 56: 112-117. PMID 30130683 DOI: 10.1016/J.Canep.2018.08.003 |
0.415 |
|
| 2018 |
Wu Y, Yu H, Zheng SL, Feng B, Kapron AL, Na R, Boyle JL, Shah S, Shi Z, Ewing CM, Wiley KE, Luo J, Walsh PC, Carter HB, Helfand BT, ... Cooney KA, et al. Germline mutations in PPFIBP2 are associated with lethal prostate cancer. The Prostate. PMID 30043417 DOI: 10.1002/Pros.23697 |
0.655 |
|
| 2018 |
Cooney KA, Beebe-Dimmer JL. Finding a Needle in the Haystack: The Search for Germline Variants Associated with Prostate Cancer Clinical Outcomes. European Urology. PMID 30029823 DOI: 10.1016/J.Eururo.2018.07.001 |
0.599 |
|
| 2018 |
Pilié PG, Cooney KA. Broadening the View of Germline Mutations in Kidney Cancer. Jama Oncology. 4: 1235-1236. PMID 29978199 DOI: 10.1001/Jamaoncol.2018.2015 |
0.392 |
|
| 2018 |
Wu Y, Yu H, Zheng SL, Na R, Mamawala M, Landis T, Wiley K, Petkewicz J, Shah S, Shi Z, Novakovic K, McGuire M, Brendler CB, Ding Q, Helfand BT, ... ... Cooney KA, et al. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. The Prostate. PMID 29520813 DOI: 10.1002/Pros.23505 |
0.607 |
|
| 2018 |
Beebe-Dimmer JL, Zuhlke KA, Johnson AM, Liesman D, Cooney KA. Rare germline mutations in African American men diagnosed with early-onset prostate cancer. The Prostate. PMID 29356034 DOI: 10.1002/Pros.23464 |
0.644 |
|
| 2018 |
Cooney KA. Inherited Predisposition to Prostate Cancer: From Gene Discovery to Clinical Impact. Transactions of the American Clinical and Climatological Association. 128: 14-23. PMID 28790484 |
0.624 |
|
| 2018 |
Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Schwartz KL, Bolton A, Heath EI. Incidence, patterns of treatment, and survival among men newly diagnosed with advanced prostate cancer: An analysis of SEER-Medicare data. Journal of Clinical Oncology. 36: 265-265. DOI: 10.1200/Jco.2018.36.6_Suppl.265 |
0.521 |
|
| 2018 |
Hahn AW, Kapron AL, Boyle J, Kohlmann W, Poole A, Gill DM, Greenberg S, Hale P, Teerlink C, Maughan BL, Cannon-Albright L, Agarwal N, Cooney KA. Prevalence of clinically actionable germline pathogenic variants (PVs) in advanced prostate cancer (aPC). Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy284.050 |
0.631 |
|
| 2017 |
Hussain M, Daignault-Newton S, Twardowski PW, Albany C, Stein MN, Kunju LP, Siddiqui J, Wu YM, Robinson D, Lonigro RJ, Cao X, Tomlins SA, Mehra R, Cooney KA, Montgomery B, et al. Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017757310. PMID 29261439 DOI: 10.1200/Jco.2017.75.7310 |
0.447 |
|
| 2017 |
Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017741173. PMID 29236593 DOI: 10.1200/Jco.2017.74.1173 |
0.486 |
|
| 2017 |
Chen H, Ewing CM, Zheng S, Grindedaal EM, Cooney KA, Wiley K, Djurovic S, Andreassen OA, Axcrona K, Mills IG, Xu J, Maehle L, Fosså SD, Isaacs WB. Genetic factors influencing prostate cancer risk in Norwegian men. The Prostate. PMID 29181843 DOI: 10.1002/Pros.23453 |
0.595 |
|
| 2017 |
Pilié PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, Cooney KA. Germline genetic variants in men with prostate cancer and one or more additional cancers. Cancer. PMID 28657667 DOI: 10.1002/Cncr.30817 |
0.676 |
|
| 2017 |
Larson NB, McDonnell S, Cannon Albright L, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E, Schleutker J, Carpten JD, Powell I, Bailey-Wilson JE, Cussenot O, et al. gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels. Genetic Epidemiology. PMID 28211093 DOI: 10.1002/Gepi.22036 |
0.344 |
|
| 2017 |
Hussain M, Daignault S, Twardowski P, Albany C, Stein MN, Kunju LP, Robinson DR, Cooney KA, Montgomery RB, Antonarakis ES, Shevrin DH, Corn PG, Whang YE, Smith DC, Caram MV, et al. Abiraterone + prednisone (Abi) +/- veliparib (Vel) for patients (pts) with metastatic castration-resistant prostate cancer (CRPC): NCI 9012 updated clinical and genomics data. Journal of Clinical Oncology. 35: 5001-5001. DOI: 10.1200/Jco.2017.35.15_Suppl.5001 |
0.349 |
|
| 2017 |
Goswami MT, Hovelson DH, Johnson A, Tomlins SA, Wang L, Zhulke K, Singh B, Anand SK, Cani A, Liu A, Kamberov S, Wu Y, Robinson D, Chinnaiyan A, Cooney KA. Abstract 1447: Identification of an oncogenic germlineKRAStruncating mutation in hereditary cancers Cancer Research. 77: 1447-1447. DOI: 10.1158/1538-7445.Am2017-1447 |
0.444 |
|
| 2017 |
Na R, S. Lilly SL, Han M, Yu H, Jiang D, Shah S, Ewing C, Zhang L, Novakovic K, Petkewicz J, Gulukota K, Helseth Jr D, Quinn M, Humphries E, Wiley K, ... ... Cooney K, et al. MP57-01 GERMLINE MUTATIONS IN DNA REPAIR GENES ARE SIGNIFICANTLY ENRICHED IN LETHAL PROSTATE CANCER AND ARE ASSOCIATED WITH DISEASE SURVIVAL Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1775 |
0.562 |
|
| 2016 |
Jackson WC, Feng FY, Daignault S, Hussain M, Smith D, Cooney K, Pienta K, Jolly S, Hollenbeck B, Olson KB, Sandler HM, Ray ME, Hamstra DA. A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy. Advances in Radiation Oncology. 1: 59-66. PMID 28799570 DOI: 10.1016/J.Adro.2015.11.001 |
0.421 |
|
| 2016 |
Na R, Zheng SL, Han M, Yu H, Jiang D, Shah S, Ewing CM, Zhang L, Novakovic K, Petkewicz J, Gulukota K, Helseth DL, Quinn M, Humphries E, Wiley KE, ... ... Cooney KA, et al. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. European Urology. PMID 27989354 DOI: 10.1016/S1569-9056(17)30541-9 |
0.622 |
|
| 2016 |
Stoffel EM, Cooney KA. Advances in inherited cancers: Introduction. Seminars in Oncology. 43: 527. PMID 27899182 DOI: 10.1053/J.Seminoncol.2016.09.003 |
0.466 |
|
| 2016 |
Cooney KA, Beebe-Dimmer JL. HOXB13 mutations and prostate cancer risk Bju International. 118: 496-497. PMID 27625331 DOI: 10.1111/Bju.13477 |
0.627 |
|
| 2016 |
Larson NB, McDonnell S, Albright LC, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E, Schleutker J, Carpten JD, Powell I, Bailey-Wilson J, Cussenot O, et al. Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies. Genetic Epidemiology. PMID 27312771 DOI: 10.1002/Gepi.21983 |
0.379 |
|
| 2016 |
Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, et al. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. Human Genetics. PMID 27262462 DOI: 10.1007/S00439-016-1690-6 |
0.535 |
|
| 2016 |
Pilie PG, Giri VN, Cooney KA. HOXB13 and other high penetrant genes for prostate cancer. Asian Journal of Andrology. PMID 27034017 DOI: 10.4103/1008-682X.175785 |
0.588 |
|
| 2016 |
Hertz DL, Caram MV, Kidwell KM, Thibert JN, Gersch C, Seewald NJ, Smerage J, Rubenfire M, Henry NL, Cooney KA, Leja M, Griggs JJ, Rae JM. Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines. Pharmacogenomics. PMID 26799497 DOI: 10.2217/Pgs.15.162 |
0.337 |
|
| 2016 |
Caram ME, Skolarus TA, Cooney KA. Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. European Urology. PMID 26776937 DOI: 10.1016/J.Eururo.2015.12.045 |
0.638 |
|
| 2016 |
Hussain M, Daignault S, Twardowski P, Albany C, Stein MN, Kunju LP, Siddiqui J, Robinson D, Mehra R, Cooney KA, Montgomery RB, Antonarakis ES, Shevrin DH, Corn PG, Whang YE, et al. Co-targeting androgen receptor (AR) and DNA repair: A randomized ETS gene fusion-stratified trial of abiraterone + prednisone (Abi) +/- the PARP1 inhibitor veliparib for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) (NCI9012)--A University of Chicago phase II consortium trial. Journal of Clinical Oncology. 34: 5010-5010. DOI: 10.1200/Jco.2016.34.15_Suppl.5010 |
0.42 |
|
| 2016 |
Cropp CD, McDonnell SK, Middha S, DeRycke M, Karyadi DM, Schaid D, Thibodeau SN, Isaacs WB, Ostrander EA, Stanford J, Cooney KA, Bailey-Wilson JE, Carpten JD. Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B40 |
0.584 |
|
| 2015 |
Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, ... ... Cooney KA, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 162: 454. PMID 28843286 DOI: 10.1016/J.Cell.2015.06.053 |
0.589 |
|
| 2015 |
Lange EM, Ribado J, Zuhlke KA, Johnson A, Keele G, Li J, Wang Y, Duan Q, Li G, Gao Z, Li Y, Xu J, Zheng SL, Cooney KA. Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26671023 DOI: 10.1158/1055-9965.Epi-14-0995 |
0.633 |
|
| 2015 |
Kadakia KC, Tomlins SA, Sanghvi SK, Cani AK, Omata K, Hovelson DH, Liu CJ, Cooney KA. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment. Journal of Hematology & Oncology. 8: 109. PMID 26444865 DOI: 10.1186/S13045-015-0204-7 |
0.634 |
|
| 2015 |
Beebe-Dimmer JL, Hathcock M, Yee C, Okoth LA, Ewing CM, Isaacs WB, Cooney KA, Thibodeau SN. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1366-72. PMID 26108461 DOI: 10.1158/1055-9965.Epi-15-0247 |
0.626 |
|
| 2015 |
Caram ME, Guo C, Leja M, Smerage J, Henry NL, Giacherio D, Rubenfire M, Schott A, Davis M, Hayes DF, Van Poznak C, Cooney KA, Hertz DL, Banerjee M, Griggs JJ. Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer. Breast Cancer Research and Treatment. 152: 163-72. PMID 26050157 DOI: 10.1007/S10549-015-3454-8 |
0.315 |
|
| 2015 |
Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, ... ... Cooney KA, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 161: 1215-28. PMID 26000489 DOI: 10.1016/J.Cell.2015.05.001 |
0.624 |
|
| 2015 |
Hovelson DH, McDaniel AS, Cani AK, Johnson B, Rhodes K, Williams PD, Bandla S, Bien G, Choppa P, Hyland F, Gottimukkala R, Liu G, Manivannan M, Schageman J, Ballesteros-Villagrana E, ... ... Cooney KA, et al. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia (New York, N.Y.). 17: 385-99. PMID 25925381 DOI: 10.1016/J.Neo.2015.03.004 |
0.402 |
|
| 2015 |
Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, ... ... Cooney KA, et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1121-9. PMID 25837820 DOI: 10.1158/1055-9965.Epi-14-0317 |
0.666 |
|
| 2015 |
Grasso CS, Cani AK, Hovelson DH, Quist MJ, Douville NJ, Yadati V, Amin AM, Nelson PS, Betz BL, Liu CJ, Knudsen KE, Cooney KA, Feng FY, McDaniel AS, Tomlins SA. Integrative molecular profiling of routine clinical prostate cancer specimens. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 1110-8. PMID 25735316 DOI: 10.1093/Annonc/Mdv134 |
0.596 |
|
| 2015 |
Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, ... ... Cooney KA, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9 |
0.466 |
|
| 2015 |
Hovelson DH, Cani AK, McDaniel A, Johnson B, Rhodes K, Williams PD, Bandla S, Choppa P, Hyland F, Liu G, Schageman J, Yadati V, Amin A, Cooney KA, Feng FY, et al. The Oncomine Cancer Research Panel, a scalable next-generation sequencing system for relevant somatic variant assessment in solid tumors. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E22164 |
0.387 |
|
| 2015 |
Pilie P, Johnson AM, Zuhlke KA, Okoth LA, Tomlins S, Cooney KA. Identification of germline mutations in men with early onset prostate cancer. Journal of Clinical Oncology. 33: 5045-5045. DOI: 10.1200/Jco.2015.33.15_Suppl.5045 |
0.645 |
|
| 2015 |
Kozminsky M, Yoon HJ, Palanisamy N, Cooney K, Hussain M, Alva A, Morgan T, Nagrath S. Abstract 1585: Application of a graphene oxide based microfluidic device (GO Chip) to prostate cancer circulating tumor cell capture and analysis Cancer Research. 75: 1585-1585. DOI: 10.1158/1538-7445.Am2015-1585 |
0.565 |
|
| 2015 |
Stoffel EM, Koeppe ES, Zuhlke KA, Appelman HD, Essien BE, Photenhauer A, Cooney KA, Rozek L, Merchant JL. Su1941 Germline Variant in Hnf1a Is Overrepresented Among Individuals With Young Onset Colorectal Cancer Gastroenterology. 148: S-556. DOI: 10.1016/S0016-5085(15)31870-9 |
0.423 |
|
| 2014 |
Johnson AM, Zuhlke KA, Plotts C, McDonnell SK, Middha S, Riska SM, Schaid DJ, Thibodeau SN, Douglas JA, Cooney KA. Mutational landscape of candidate genes in familial prostate cancer. The Prostate. 74: 1371-8. PMID 25111073 DOI: 10.1002/Pros.22849 |
0.564 |
|
| 2014 |
Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer. 120: 2735-41. PMID 24842808 DOI: 10.1002/Cncr.28769 |
0.61 |
|
| 2014 |
Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Prostate cancer in young men: an important clinical entity. Nature Reviews. Urology. 11: 317-23. PMID 24818853 DOI: 10.1038/Nrurol.2014.91 |
0.663 |
|
| 2014 |
Zuhlke KA, Johnson AM, Tomlins SA, Palanisamy N, Carpten JD, Lange EM, Isaacs WB, Cooney KA. Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer. The Prostate. 74: 983-90. PMID 24796539 DOI: 10.1002/Pros.22818 |
0.669 |
|
| 2014 |
Ishak-Howard MB, Okoth LA, Cooney KA. Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer. Urology. 83: 1356-61. PMID 24745796 DOI: 10.1016/J.Urology.2014.02.015 |
0.623 |
|
| 2014 |
Lange EM, Johnson AM, Wang Y, Zuhlke KA, Lu Y, Ribado JV, Keele GR, Li J, Duan Q, Li G, Gao Z, Li Y, Xu J, Isaacs WB, Zheng S, ... Cooney KA, et al. Genome-wide association scan for variants associated with early-onset prostate cancer. Plos One. 9: e93436. PMID 24740154 DOI: 10.1371/Journal.Pone.0093436 |
0.654 |
|
| 2014 |
Smith SC, Palanisamy N, Zuhlke KA, Johnson AM, Siddiqui J, Chinnaiyan AM, Kunju LP, Cooney KA, Tomlins SA. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey. The American Journal of Surgical Pathology. 38: 615-26. PMID 24722062 DOI: 10.1097/Pas.0000000000000090 |
0.618 |
|
| 2014 |
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, ... ... Cooney KA, et al. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Human Genetics. 133: 347-56. PMID 24162621 DOI: 10.1007/S00439-013-1384-2 |
0.685 |
|
| 2014 |
Beebe-Dimmer JL, Isaacs WB, Zuhlke KA, Yee C, Walsh PC, Isaacs SD, Johnson AM, Ewing CE, Humphreys EB, Chowdhury WH, Montie JE, Cooney KA. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy. Bju International. 113: 830-5. PMID 24148311 DOI: 10.1111/Bju.12522 |
0.633 |
|
| 2014 |
Lange EM, Johnson AM, Wang Y, Zuhlke KA, Lu Y, Ribado JV, Keele GR, Li J, Duan Q, Li G, Gao Z, Li Y, Xu J, Isaacs WB, Zheng S, ... Cooney KA, et al. Genome-wide association scan for variants associated with early-onset prostate cancer Plos One. 9. DOI: 10.1371/journal.pone.0093436.t001 |
0.513 |
|
| 2014 |
Grivas P, Daignault S, Cooney KA, Jacobson J, Yablon C, Ross BD, Chenevert TL, Hoff B, Rehemtulla A, Keller ET, Mehra R, Shelley G, Alva AS, Hussain M, Smith DC. Cabozantinib (Cabo) in patients (pts) with castrate-resistant prostate cancer (CRPC) metastatic to bone (NCT01428219): Evaluation of bone metastasis microenvironment. Journal of Clinical Oncology. 32: e16015-e16015. DOI: 10.1200/Jco.2014.32.15_Suppl.E16015 |
0.454 |
|
| 2014 |
Davis EJ, Yee C, Beebe-Dimmer J, Cooney KA. The risk of second malignancies after treatment for localized prostate cancer. Journal of Clinical Oncology. 32: 5034-5034. DOI: 10.1200/Jco.2014.32.15_Suppl.5034 |
0.62 |
|
| 2014 |
Beebe-Dimmer J, Isaacs WB, Thibodeau SN, Yee C, Ewing C, Okoth L, Cooney KA. Association of the HOXB13 G84E mutation with increased risk for prostate cancer and other malignancies. Journal of Clinical Oncology. 32: 1558-1558. DOI: 10.1200/Jco.2014.32.15_Suppl.1558 |
0.624 |
|
| 2014 |
Jackson W, Feng FY, Daignault S, Hussain M, Smith D, Cooney K, Pienta K, Jolly S, Hollenbeck B, Olson KB, Sandler HM, Ray ME, Hamstra DA. A Phase 2 Trial of Salvage Radiation and Concurrent Weekly Docetaxel After Rising PSA Post–Radical Prostatectomy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1360 |
0.308 |
|
| 2013 |
Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, ... ... Cooney KA, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics. 45: 385-91, 391e1-2. PMID 23535732 DOI: 10.1038/Ng.2560 |
0.661 |
|
| 2013 |
Raymond VM, Mukherjee B, Wang F, Huang SC, Stoffel EM, Kastrinos F, Syngal S, Cooney KA, Gruber SB. Elevated risk of prostate cancer among men with Lynch syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1713-8. PMID 23530095 DOI: 10.1200/Jco.2012.44.1238 |
0.673 |
|
| 2013 |
Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013: 560857. PMID 23476788 DOI: 10.1155/2013/560857 |
0.557 |
|
| 2013 |
Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, ... ... Cooney KA, et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics. 22: 408-15. PMID 23065704 DOI: 10.1093/Hmg/Dds425 |
0.502 |
|
| 2013 |
Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, ... ... Cooney KA, et al. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 132: 5-14. PMID 23064873 DOI: 10.1007/S00439-012-1229-4 |
0.688 |
|
| 2013 |
Schroeck FR, Zuhlke KA, Siddiqui J, Siddiqui R, Cooney KA, Wei JT. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. The Journal of Urology. 189: 849-53. PMID 23036981 DOI: 10.1016/J.Juro.2012.09.117 |
0.658 |
|
| 2013 |
Grivas P, Daignault S, Cooney KA, Jacobson J, Yablon C, Ross BD, Chenevert TL, Galbán CJ, Rehemtulla A, Keller ET, Kunju P, Mehra R, Escara-Wilke J, Shelley G, Pienta KJ, et al. A phase II trial of cabozantinib (Cabo) in patients (pts) with castrate-resistant prostate cancer (CRPC) metastatic to bone (NCT01428219). Journal of Clinical Oncology. 31: TPS5094-TPS5094. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps5094 |
0.358 |
|
| 2013 |
Zuhlke KA, Johnson AM, Tomlins SA, Palanisamy N, Robbins CM, Tembe WA, Carpten JD, Lange EM, Isaacs WB, Cooney KA. Abstract 2564: Identification of a novel SPOP missense mutation from targeted next-generation sequencing of men with chromosome 17-q linkage. Epidemiology. 73: 2564-2564. DOI: 10.1158/1538-7445.Am2013-2564 |
0.322 |
|
| 2013 |
Asmar R, Beebe-Dimmer JL, Korgavkar K, Keele GR, Cooney KA. Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy Prostate Cancer and Prostatic Diseases. 16: 61-65. DOI: 10.1038/Pcan.2012.32 |
0.575 |
|
| 2013 |
Beebe-Dimmer J, Isaacs W, Zuhlke K, Yee C, Walsh P, Isaacs S, Cooney K. 2137 THE PREVALENCE OF THE HOXB13 GLY84GLU PROSTATE CANCER RISK ALLELE IN MEN TREATED WITH RADICAL PROSTATECTOMY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2046 |
0.637 |
|
| 2012 |
Zuhlke KA, Johnson AM, Okoth LA, Stoffel EM, Robbins CM, Tembe WA, Salinas CA, Zheng SL, Xu J, Carpten JD, Lange EM, Isaacs WB, Cooney KA. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer. Familial Cancer. 11: 595-600. PMID 22864661 DOI: 10.1007/S10689-012-9555-1 |
0.658 |
|
| 2012 |
Beebe-Dimmer JL, Iyer PT, Nriagu JO, Keele GR, Mehta S, Meliker JR, Lange EM, Schwartz AG, Zuhlke KA, Schottenfeld D, Cooney KA. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Environmental Health : a Global Access Science Source. 11: 43. PMID 22747749 DOI: 10.1186/1476-069X-11-43 |
0.425 |
|
| 2012 |
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, ... ... Cooney KA, et al. Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. Bmc Medical Genetics. 13: 46. PMID 22712434 DOI: 10.1186/1471-2350-13-46 |
0.584 |
|
| 2012 |
Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, Bizon C, Yan G, Gielzak M, Partin AW, Shanmugam V, ... ... Cooney KA, et al. Germline mutations in HOXB13 and prostate-cancer risk. The New England Journal of Medicine. 366: 141-9. PMID 22236224 DOI: 10.1056/Nejmoa1110000 |
0.682 |
|
| 2012 |
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, et al. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 131: 1095-103. PMID 22198737 DOI: 10.1007/S00439-011-1136-0 |
0.568 |
|
| 2012 |
Bauer CM, Ishak MB, Johnson EK, Beebe-Dimmer JL, Cooney KA. Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer. Integrative Cancer Therapies. 11: 83-9. PMID 21821653 DOI: 10.1177/1534735411413262 |
0.664 |
|
| 2012 |
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, et al. Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. The Prostate. 72: 410-26. PMID 21748754 DOI: 10.1002/Pros.21443 |
0.503 |
|
| 2012 |
Lange EM, Salinas CA, Zuhlke KA, Ray AM, Wang Y, Lu Y, Ho LA, Luo J, Cooney KA. Early onset prostate cancer has a significant genetic component. The Prostate. 72: 147-56. PMID 21538423 DOI: 10.1002/Pros.21414 |
0.649 |
|
| 2012 |
Alva A, Slovin S, Daignault S, Carducci M, Dipaola R, Pienta K, Agus D, Cooney K, Chen A, Smith DC, Hussain M. Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium. Investigational New Drugs. 30: 749-57. PMID 21049281 DOI: 10.1007/S10637-010-9573-5 |
0.582 |
|
| 2012 |
Ishak MB, Ray AM, Robbins CM, Tembe WD, Carpten JD, Lange EM, Isaacs WB, Cooney KA. Abstract 1642: Rare missense variants inMAP3K14andARHGAP27in men with hereditary prostate cancer Cancer Research. 72: 1642-1642. DOI: 10.1158/1538-7445.Am2012-1642 |
0.623 |
|
| 2011 |
Davis E, Salinas CA, Okoth LA, Cooney KA. Risk of second primary malignancy in U.S. men diagnosed with prostate cancer from 1992 to 2007. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4543. PMID 28023388 DOI: 10.1200/Jco.2011.29.15_Suppl.4543 |
0.63 |
|
| 2011 |
Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, ... ... Cooney KA, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics. 43: 785-91. PMID 21743467 DOI: 10.1038/Ng.882 |
0.622 |
|
| 2011 |
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, ... Cooney KA, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nature Genetics. 43: 570-3. PMID 21602798 DOI: 10.1038/Ng.839 |
0.621 |
|
| 2011 |
Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Research. 71: 3442-6. PMID 21558387 DOI: 10.1158/0008-5472.Can-11-0314 |
0.632 |
|
| 2011 |
Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 23-32. PMID 21071540 DOI: 10.1158/1055-9965.Epi-10-0698 |
0.621 |
|
| 2011 |
Bauer CM, Ray AM, Halstead-Nussloch BA, Dekker RG, Raymond VM, Gruber SB, Cooney KA. Hereditary prostate cancer as a feature of Lynch syndrome. Familial Cancer. 10: 37-42. PMID 20872076 DOI: 10.1007/S10689-010-9388-8 |
0.579 |
|
| 2011 |
Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study. The Prostate. 71: 225-31. PMID 20717903 DOI: 10.1002/Pros.21234 |
0.659 |
|
| 2011 |
Bradley DA, Daignault S, Ryan CJ, Dipaola RS, Cooney KA, Smith DC, Small E, Mathew P, Gross ME, Stein MN, Chen A, Pienta KJ, Escara-Wilke J, Doyle G, Al-Hawary M, et al. Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium. Investigational New Drugs. 29: 1432-40. PMID 20336348 DOI: 10.1007/s10637-010-9420-8 |
0.548 |
|
| 2011 |
Ishak M, Cooney K. Abstract 5569: The association between statin use and risk of biochemical recurrence in men treated with radical prostatectomy in a cohort of men with inherited forms of prostate cancer Cancer Research. 71: 5569-5569. DOI: 10.1158/1538-7445.Am2011-5569 |
0.652 |
|
| 2011 |
Bradley DA, Daignault S, Ryan CJ, DiPaola RS, Cooney KA, Smith DC, Small E, Mathew P, Gross ME, Stein MN, Chen A, Pienta KJ, Escara-Wilke J, Doyle G, Al-Hawary M, et al. Erratum: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the prostate cancer clinical trials consortium (Investigational New Drugs DOI: 10.1007/s10637-010-9420-8) Investigational New Drugs. 29: 1517-1518. DOI: 10.1007/S10637-010-9502-7 |
0.577 |
|
| 2010 |
Beebe-Dimmer JL, Zuhlke KA, Ray AM, Lange EM, Cooney KA. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer and Prostatic Diseases. 13: 362-8. PMID 20697428 DOI: 10.1038/Pcan.2010.27 |
0.642 |
|
| 2010 |
Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, ... ... Cooney KA, et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. The Prostate. 70: 735-44. PMID 20333727 DOI: 10.1002/Pros.21106 |
0.507 |
|
| 2010 |
Cooney KA, Salinas CA, Ray AM, Wang Y, Lange EM, Zuhlke KA. Evaluation of the genetic component of early-onset prostate cancer. Journal of Clinical Oncology. 28: 4502-4502. DOI: 10.1200/Jco.2010.28.15_Suppl.4502 |
0.445 |
|
| 2010 |
Johnson E, Ray A, Zuhlke K, Cooney K. 1427 Bcar1 Variants In Hereditary Prostate Cancer Families With Linkage To 16Q23 The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1120 |
0.627 |
|
| 2009 |
Ray AM, Zuhlke KA, Johnson GR, Levin AM, Douglas JA, Lange EM, Cooney KA. Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families. British Journal of Cancer. 101: 2043-7. PMID 19935797 DOI: 10.1038/Sj.Bjc.6605433 |
0.602 |
|
| 2009 |
Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016 |
0.658 |
|
| 2009 |
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, ... ... Cooney KA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450 |
0.588 |
|
| 2009 |
Ahn J, Mukherjee B, Banerjee M, Cooney KA. Bayesian inference for the stereotype regression model: Application to a case-control study of prostate cancer. Statistics in Medicine. 28: 3139-57. PMID 19731262 DOI: 10.1002/Sim.3693 |
0.446 |
|
| 2009 |
Ray AM, Zuhlke KA, Levin AM, Douglas JA, Cooney KA, Petros JA. Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men. The Prostate. 69: 956-60. PMID 19267350 DOI: 10.1002/Pros.20943 |
0.607 |
|
| 2009 |
Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA. Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. The Prostate. 69: 385-91. PMID 19035517 DOI: 10.1002/Pros.20891 |
0.661 |
|
| 2009 |
Zhang L, Mukherjee B, Hu B, Moreno V, Cooney KA. Semiparametric Bayesian modeling of random genetic effects in family-based association studies. Statistics in Medicine. 28: 113-39. PMID 18792083 DOI: 10.1002/Sim.3413 |
0.394 |
|
| 2008 |
Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, Douglas JA. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. Cancer Research. 68: 6492-5. PMID 18701471 DOI: 10.1158/0008-5472.Can-08-0348 |
0.617 |
|
| 2008 |
Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA, Aloyz R, Nelson PS, Hood L, Narod SA, White KA, ... ... Cooney KA, et al. Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer Letters. 270: 173-80. PMID 18571837 DOI: 10.1016/J.Canlet.2008.05.006 |
0.619 |
|
| 2008 |
Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA, Douglas JA. Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. International Journal of Cancer. Journal International Du Cancer. 122: 2876-9. PMID 18360876 DOI: 10.1002/Ijc.23471 |
0.657 |
|
| 2008 |
Beebe-Dimmer JL, Faerber GJ, Morgenstern H, Werny D, Wojno K, Halstead-Nussloch B, Cooney KA. Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study. Urology. 71: 554-60. PMID 18308373 DOI: 10.1016/J.Urology.2007.11.049 |
0.57 |
|
| 2008 |
Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cooney KA. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. The Prostate. 68: 675-8. PMID 18288683 DOI: 10.1002/Pros.20729 |
0.661 |
|
| 2008 |
Hwang C, Oetjen KA, Kosoff D, Wojno KJ, Albertelli MA, Dunn RL, Robins DM, Cooney KA, Duckett CS. X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model Cell Death and Differentiation. 15: 831-840. PMID 18259199 DOI: 10.1038/Cdd.2008.15 |
0.532 |
|
| 2008 |
Lange EM, Sarma AV, Ray A, Wang Y, Ho LA, Anderson SA, Cunningham JM, Cooney KA. The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. Journal of Human Genetics. 53: 220-6. PMID 18217192 DOI: 10.1007/S10038-007-0240-4 |
0.659 |
|
| 2008 |
Sarma AV, Dunn RL, Lange LA, Ray A, Wang Y, Lange EM, Cooney KA. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study. The Prostate. 68: 296-305. PMID 18163429 DOI: 10.1002/Pros.20696 |
0.671 |
|
| 2008 |
Hwang C, Giri VN, Wilkinson JC, Wright CW, Wilkinson AS, Cooney KA, Duckett CS. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor Breast Cancer Research and Treatment. 107: 235-242. PMID 17453341 DOI: 10.1007/S10549-007-9542-7 |
0.359 |
|
| 2007 |
Levin AM, Zuhlke KA, Ray AM, Cooney KA, Douglas JA. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer. The Prostate. 67: 1507-13. PMID 17683075 DOI: 10.1002/Pros.20642 |
0.69 |
|
| 2007 |
Mackler NJ, Pienta KJ, Dunn RL, Cooney KA, Redman BG, Olson KB, Fardig JE, Smith DC. Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma. Clinical Genitourinary Cancer. 5: 318-22. PMID 17645828 DOI: 10.3816/Cgc.2007.N.010 |
0.526 |
|
| 2007 |
Douglas JA, Levin AM, Zuhlke KA, Ray AM, Johnson GR, Lange EM, Wood DP, Cooney KA. Common variation in the BRCA1 gene and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1510-6. PMID 17585057 DOI: 10.1158/1055-9965.Epi-07-0137 |
0.686 |
|
| 2007 |
Levin AM, Ray AM, Zuhlke KA, Douglas JA, Cooney KA. Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1294-7. PMID 17548701 DOI: 10.1158/1055-9965.Epi-06-1054 |
0.669 |
|
| 2007 |
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, ... ... Cooney KA, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Human Molecular Genetics. 16: 1271-8. PMID 17478474 DOI: 10.1093/Hmg/Ddm075 |
0.517 |
|
| 2007 |
Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, ... ... Cooney KA, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nature Genetics. 39: 638-44. PMID 17401364 DOI: 10.1038/Ng2015 |
0.664 |
|
| 2007 |
Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA. Features of the metabolic syndrome and prostate cancer in African-American men. Cancer. 109: 875-81. PMID 17265528 DOI: 10.1002/Cncr.22461 |
0.631 |
|
| 2007 |
Lange EM, Robbins CM, Gillanders EM, Zheng SL, Xu J, Wang Y, White KA, Chang BL, Ho LA, Trent JM, Carpten JD, Isaacs WB, Cooney KA. Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Human Genetics. 121: 49-55. PMID 17120048 DOI: 10.1007/S00439-006-0274-2 |
0.664 |
|
| 2007 |
Bradley DA, Dunn R, Ryan C, DiPaola R, Smith DC, Cooney KA, Mathew P, Gross M, Colevas AD, Hussain M. EMD121974 (NSC 707544, cilengitide) in asymptomatic metastatic androgen independent prostate cancer (AIPCa) patients (pts): A randomized trial by the Prostate Cancer Clinical Trials Consortium (NCI 6372) Journal of Clinical Oncology. 25: 5137-5137. DOI: 10.1200/Jco.2007.25.18_Suppl.5137 |
0.464 |
|
| 2007 |
Hussain M, Dunn R, Rathkopf D, Stadler W, Wilding G, Smith DC, Bradley D, Cooney KA, Zweibel J, Scher H. Suberoylanilide hydroxamic acid (vorinostat) post chemotherapy in hormone refractory prostate cancer (HRPC) patients (pts): A phase II trial by the Prostate Cancer Clinical Trials Consortium (NCI 6862) Journal of Clinical Oncology. 25: 5132-5132. DOI: 10.1200/Jco.2007.25.18_Suppl.5132 |
0.424 |
|
| 2007 |
Sarma AV, Lange L, Ray A, Lange E, Dunn RL, Cooney KA. 456: Genetic Polymorphisms in CYP17, CYPJA4, CYP19 and SRD5A2 and Prostate Cancer Risk in African American Men: the Flint Men's Health Study Journal of Urology. 177: 153-153. DOI: 10.1016/S0022-5347(18)30709-2 |
0.596 |
|
| 2006 |
Beebe-Dimmer JL, Drake EA, Dunn RL, Bock CH, Montie JE, Cooney KA. Association between family history of prostate and breast cancer among African-American men with prostate cancer. Urology. 68: 1072-6. PMID 17095075 DOI: 10.1016/J.Urology.2006.06.028 |
0.637 |
|
| 2006 |
Wang X, Wang F, Taniguchi K, Seelan RS, Wang L, Zarfas KE, McDonnell SK, Qian C, Pan K, Lu Y, Shridhar V, Couch FJ, Tindall DJ, Beebe-Dimmer JL, Cooney KA, et al. Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. Cancer Research. 66: 10302-7. PMID 17079449 DOI: 10.1158/0008-5472.Can-06-0638 |
0.639 |
|
| 2006 |
Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proceedings of the National Academy of Sciences of the United States of America. 103: 14068-73. PMID 16945910 DOI: 10.1073/Pnas.0605832103 |
0.651 |
|
| 2006 |
Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, ... ... Cooney KA, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Human Genetics. 120: 471-85. PMID 16932970 DOI: 10.1007/s00439-006-0219-9 |
0.6 |
|
| 2006 |
Sarma AV, McLaughlin JC, Wallner LP, Dunn RL, Cooney KA, Schottenfeld D, Montie JE, Wei JT. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. The Journal of Urology. 176: 1108-13. PMID 16890703 DOI: 10.1016/J.Juro.2006.04.075 |
0.629 |
|
| 2006 |
White KA, Lange EM, Ray AM, Wojno KJ, Cooney KA. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q. Prostate Cancer and Prostatic Diseases. 9: 298-302. PMID 16733518 DOI: 10.1038/Sj.Pcan.4500878 |
0.519 |
|
| 2006 |
Beekman KW, Colevas AD, Cooney K, Dipaola R, Dunn RL, Gross M, Keller ET, Pienta KJ, Ryan CJ, Smith D, Hussain M. Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design. Clinical Genitourinary Cancer. 4: 299-302. PMID 16729916 DOI: 10.3816/Cgc.2006.N.012 |
0.548 |
|
| 2006 |
Hebbring SJ, Fredriksson H, White KA, Maier C, Ewing C, McDonnell SK, Jacobsen SJ, Cerhan J, Schaid DJ, Ikonen T, Autio V, Tammela TL, Herkommer K, Paiss T, Vogel W, ... ... Cooney KA, et al. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 935-8. PMID 16702373 DOI: 10.1158/1055-9965.Epi-05-0910 |
0.667 |
|
| 2006 |
Mackler NJ, Dunn RL, Hellerstedt B, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC. Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate. Cancer. 106: 2617-23. PMID 16691618 DOI: 10.1002/Cncr.21927 |
0.548 |
|
| 2006 |
Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, ... ... Cooney KA, et al. A common variant associated with prostate cancer in European and African populations. Nature Genetics. 38: 652-8. PMID 16682969 DOI: 10.1038/Ng1808 |
0.648 |
|
| 2006 |
Poynter JN, Cooney KA, Bonner JD, White KA, Tomsho LP, Rennert G, Gruber SB. APC I1307K and the risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 468-73. PMID 16537703 DOI: 10.1158/1055-9965.Epi-05-0584 |
0.693 |
|
| 2006 |
Lange EM, Ho LA, Beebe-Dimmer JL, Wang Y, Gillanders EM, Trent JM, Lange LA, Wood DP, Cooney KA. Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12. Human Genetics. 119: 400-7. PMID 16508751 DOI: 10.1007/S00439-006-0149-6 |
0.568 |
|
| 2006 |
Ray ME, Wojno KJ, Goldstein NS, Olson KB, Shah RB, Cooney KA. Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. Urology. 67: 423.e5-423.e8. PMID 16461109 DOI: 10.1016/J.Urology.2005.08.013 |
0.48 |
|
| 2006 |
Chang BL, Lange EM, Dimitrov L, Valis CJ, Gillanders EM, Lange LA, Wiley KE, Isaacs SD, Wiklund F, Baffoe-Bonnie A, Langefeld CD, Zheng SL, Matikainen MP, Ikonen T, Fredriksson H, ... ... Cooney KA, et al. Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. Human Genetics. 118: 716-24. PMID 16328469 DOI: 10.1007/S00439-005-0099-4 |
0.606 |
|
| 2006 |
Beebe-Dimmer JL, Lange LA, Cain JE, Lewis RC, Ray AM, Sarma AV, Lange EM, Cooney KA. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men. Prostate Cancer and Prostatic Diseases. 9: 50-5. PMID 16247489 DOI: 10.1038/Sj.Pcan.4500840 |
0.599 |
|
| 2006 |
Slager SL, Zarfas KE, Brown WM, Lange EM, McDonnell SK, Wojno KJ, Cooney KA. Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project. The Prostate. 66: 173-9. PMID 16173044 DOI: 10.1002/Pros.20332 |
0.595 |
|
| 2006 |
Cooney KA. Adult urologyOncology: Prostate/testis/penis/urethraEditorial Comment The Journal of Urology. 176. DOI: 10.1016/J.Juro.2006.07.210 |
0.535 |
|
| 2005 |
Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA. Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2035-9. PMID 16103457 DOI: 10.1158/1055-9965.Epi-05-0170 |
0.681 |
|
| 2005 |
Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, ... ... Cooney KA, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. American Journal of Human Genetics. 77: 219-29. PMID 15988677 DOI: 10.1086/432377 |
0.505 |
|
| 2005 |
Claeys GB, Sarma AV, Dunn RL, Zuhlke KA, Beebe-Dimmer J, Montie JE, Wojno KJ, Schottenfeld D, Cooney KA. INSPstI polymorphism and prostate cancer in African-American men. The Prostate. 65: 83-7. PMID 15880482 DOI: 10.1002/Pros.20271 |
0.661 |
|
| 2005 |
Bock CH, Peyser PA, Montie JE, Cooney KA. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families. The Prostate. 64: 60-6. PMID 15651090 DOI: 10.1002/Pros.20220 |
0.667 |
|
| 2005 |
Cooney KA, Gruber SB. Hyperglycemia, obesity, and cancer risks on the horizon. Jama. 293: 235-6. PMID 15644552 DOI: 10.1001/Jama.293.2.235 |
0.339 |
|
| 2004 |
Sarma AV, McLaughlin JC, Jacobsen SJ, Logie J, Dolin P, Dunn RL, Cooney KA, Montie JE, Schottenfeld D, Wei JT. Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study. Urology. 64: 959-65. PMID 15533486 DOI: 10.1016/J.Urology.2004.06.043 |
0.459 |
|
| 2004 |
Zuhlke KA, Madeoy JJ, Beebe-Dimmer J, White KA, Griffin A, Lange EM, Gruber SB, Ostrander EA, Cooney KA. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5975-80. PMID 15447980 DOI: 10.1158/1078-0432.Ccr-04-0554 |
0.654 |
|
| 2004 |
Gillanders EM, Xu J, Chang BL, Lange EM, Wiklund F, Bailey-Wilson JE, Baffoe-Bonnie A, Jones M, Gildea D, Riedesel E, Albertus J, Isaacs SD, Wiley KE, Mohai CE, Matikainen MP, ... ... Cooney KA, et al. Combined genome-wide scan for prostate cancer susceptibility genes. Journal of the National Cancer Institute. 96: 1240-7. PMID 15316059 DOI: 10.1093/Jnci/Djh228 |
0.683 |
|
| 2004 |
Giri VN, Cassidy AE, Beebe-Dimmer J, Ellis L, Smith DC, Bock CH, Cooney KA. Association between Agent Orange and prostate cancer: a pilot case-control study. Urology. 63: 757-60; discussion 7. PMID 15072895 DOI: 10.1016/J.Urology.2003.11.044 |
0.654 |
|
| 2004 |
Beebe-Dimmer JL, Wood DP, Gruber SB, Chilson DM, Zuhlke KA, Claeys GB, Cooney KA. Risk perception and concern among brothers of men with prostate carcinoma. Cancer. 100: 1537-44. PMID 15042690 DOI: 10.1002/Cncr.20121 |
0.454 |
|
| 2004 |
Beebe-Dimmer JL, Wood DP, Gruber SB, Douglas JA, Bonner JD, Mohai C, Zuhlke KA, Shepherd C, Cooney KA. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology. 63: 282-7. PMID 14972472 DOI: 10.1016/J.Urology.2003.09.036 |
0.613 |
|
| 2004 |
Brown WM, Lange EM, Chen H, Zheng SL, Chang B, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cooney KA. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci. British Journal of Cancer. 90: 510-4. PMID 14735201 DOI: 10.1038/Sj.Bjc.6601417 |
0.678 |
|
| 2004 |
Sarma AV, McLaughlin JC, Jacobsen SJ, Dunn RL, Cooney KA, Montie JE, Schottenfeld D, Wei JT. 1547: Health-Seeking Behavior and Lower Urinary Tract Symptoms among a Cohort of African-American Men: The Flint Men's Healthstudy Journal of Urology. 171: 408-408. DOI: 10.1016/S0022-5347(18)38755-X |
0.326 |
|
| 2004 |
Sarma AV, McLaughlin JC, Jacobsen SJ, Dunn RL, Wei JT, Montie JE, Schottenfeld D, Cooney KA. 443: Sexual Behavior, Sexually Transmitted Diseases, and the Risk of Prostate Cancer in African American Men: The Flint Men’s Health Study Journal of Urology. 171: 117-117. DOI: 10.1016/S0022-5347(18)37705-X |
0.476 |
|
| 2004 |
Giri VN, Cassidy AE, Beebe-Dimmer J, Ellis LR, Smith DC, Bock CH, Cooney KA. Erratum: Association between agent orange and prostate cancer: A pilot case-control study (Urology (April 2004) 63 (757-761)) Urology. 63. DOI: 10.1016/J.Urology.2004.05.001 |
0.617 |
|
| 2003 |
Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, Dimmer JB, Montie JE, Trent JM, ... Cooney KA, et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. The Prostate. 57: 326-34. PMID 14601029 DOI: 10.1002/Pros.10307 |
0.663 |
|
| 2003 |
Ray ME, Dunn RL, Cooney KA, Sandler HM. Family history of prostate cancer and relapse after definitive external beam radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 57: 371-6. PMID 12957247 DOI: 10.1016/S0360-3016(03)00504-2 |
0.567 |
|
| 2003 |
Bock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA. Prostate cancer early detection practices among men with a family history of disease. Urology. 62: 470-5. PMID 12946749 DOI: 10.1016/S0090-4295(03)00382-0 |
0.67 |
|
| 2003 |
Miller DC, Zheng SL, Dunn RL, Sarma AV, Montie JE, Lange EM, Meyers DA, Xu J, Cooney KA. Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. Cancer Research. 63: 3486-9. PMID 12839931 |
0.591 |
|
| 2003 |
Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, Lieber MM, Cooney KA, Schottenfeld D, Montie JE, Jacobsen SJ. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology. 61: 1086-91. PMID 12809866 DOI: 10.1016/S0090-4295(03)00154-7 |
0.438 |
|
| 2003 |
Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JM, James SA, Cooney KA, Doerr KM, Montie JE, Schottenfeld D. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. American Journal of Epidemiology. 157: 906-14. PMID 12746243 DOI: 10.1093/Aje/Kwg051 |
0.411 |
|
| 2003 |
Chen H, Griffin AR, Wu YQ, Tomsho LP, Zuhlke KA, Lange EM, Gruber SB, Cooney KA. RNASEL mutations in hereditary prostate cancer Journal of Medical Genetics. 40. PMID 12624150 DOI: 10.1136/Jmg.40.3.E21 |
0.681 |
|
| 2003 |
Gruber SB, Chen H, Tomsho LP, Lee N, Perrone EE, Cooney KA. R726L androgen receptor mutation is uncommon in prostate cancer families in the united states. The Prostate. 54: 306-9. PMID 12539229 DOI: 10.1002/Pros.10195 |
0.653 |
|
| 2002 |
Joseph MA, Wei JT, Harlow SD, Cooney KA, Dunn RL, Jaffe CA, Montie JE, Schottenfeld D. Relationship of serum sex-steroid hormones and prostate volume in African American men. The Prostate. 53: 322-9. PMID 12430143 DOI: 10.1002/Pros.10154 |
0.515 |
|
| 2002 |
Kotsis SV, Spencer SL, Peyser PA, Montie JE, Cooney KA. Early onset prostate cancer: predictors of clinical grade. The Journal of Urology. 167: 1659-63. PMID 11912383 DOI: 10.1016/S0022-5347(05)65173-7 |
0.69 |
|
| 2002 |
Sarma AV, Jaffe CA, Schottenfeld D, Dunn R, Montie JE, Cooney KA, Wei JT. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. Urology. 59: 362-7. PMID 11880071 DOI: 10.1016/S0090-4295(01)01546-1 |
0.583 |
|
| 2002 |
Ray ME, Dunn RL, Cooney KA, Sandler HM. Family history of prostate cancer does not predict biochemical failure after definitive external beam radiation therapy International Journal of Radiation Oncology Biology Physics. 54: 65-66. DOI: 10.1016/S0360-3016(02)03169-3 |
0.507 |
|
| 2001 |
Wu YQ, Chen H, Rubin MA, Wojno KJ, Cooney KA. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer Cancer Research. 61: 8651-8653. PMID 11751379 |
0.577 |
|
| 2001 |
Wei JT, Schottenfeld D, Cooper K, Taylor JM, Faerber GJ, Velarde MA, Bree R, Montie JE, Cooney KA. The natural history of lower urinary tract symptoms in black american men: Relationships with aging, prostate size, flow rate and bothersomeness Journal of Urology. 165: 1521-1525. PMID 11342910 DOI: 10.1016/S0022-5347(05)66341-0 |
0.476 |
|
| 2001 |
Bock CH, Cunningham JM, McDonnell SK, Schaid DJ, Peterson BJ, Pavlic RJ, Schroeder JJ, Klein J, French AJ, Marks A, Thibodeau SN, Lange EM, Cooney KA. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. American Journal of Human Genetics. 68: 795-801. PMID 11179028 DOI: 10.1086/318797 |
0.664 |
|
| 2001 |
Heeringa SG, Alcser KH, Doerr K, Strawderman M, Cooney K, Medbery B, Schottenfeld D. Potential selection bias in a community-based study of PSA levels in African-American men Journal of Clinical Epidemiology. 54: 142-148. PMID 11166529 DOI: 10.1016/S0895-4356(00)00270-5 |
0.638 |
|
| 2001 |
Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH, Heeringa SG, Taylor JMG, Wei JT, Montie JE, Schottenfeld D. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men Urology. 57: 91-96. PMID 11164150 DOI: 10.1016/S0090-4295(00)00873-6 |
0.585 |
|
| 2000 |
Perrone EE, Theoharis C, Mucci NR, Hayasaka S, Taylor JM, Cooney KA, Rubin MA. Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. Journal of the National Cancer Institute. 92: 937-9. PMID 10841830 DOI: 10.1093/Jnci/92.11.937 |
0.571 |
|
| 2000 |
Lange EM, Chen H, Brierley K, Livermore H, Wojno KJ, Langefeld CD, Lange K, Cooney KA. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer Cancer Epidemiology Biomarkers and Prevention. 9: 439-442. PMID 10794490 |
0.646 |
|
| 1999 |
Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX Clinical Cancer Research. 5: 4013-4020. PMID 10632333 |
0.578 |
|
| 1999 |
Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, Cooney KA. Androgen deprivation therapy for prostate cancer results in significant loss of bone density Urology. 54: 607-611. PMID 10510915 DOI: 10.1016/S0090-4295(99)00301-5 |
0.6 |
|
| 1999 |
Cooney KA, Tsou HC, Petty EM, Miesfeldt S, Ping XL, Gruener AC, Peacocke M. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer Clinical Cancer Research. 5: 1387-1391. PMID 10389923 |
0.637 |
|
| 1999 |
Daniell HW, Wei J, Gravlin K, Cooney KA. Re: Osteoporosis after orchiectomy for prostate cancer [3] Journal of Urology. 160: 1809. PMID 9783964 DOI: 10.1016/S0022-5347(01)62422-4 |
0.609 |
|
| 1998 |
Cooney KA. Hereditary prostate cancer in African-American families Seminars in Urologic Oncology. 16: 202-206. PMID 9858326 |
0.605 |
|
| 1998 |
Cooney K, McCarthy J, Lange E, Huang L, Miesfeldt S, Montie J, Oesterling J, Sandler H, Lange K. Prostate Cancer Susceptibility Locus on Chromosome 1q: A Confirmatory Study Journal of Urology. 160: 264-265. DOI: 10.1016/S0022-5347(01)63103-3 |
0.576 |
|
| 1997 |
Cooney KA, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, Oesterling JE, Sandler HM, Lange K. Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study Journal of the National Cancer Institute. 89: 955-959. PMID 9214675 DOI: 10.1093/Jnci/89.13.955 |
0.619 |
|
| 1996 |
Cooney KA, Wetzel JC, Consolino CM, Wojno KJ. Identification and characterization of proximal 6q deletions in prostate cancer Cancer Research. 56: 4150-4153. PMID 8797584 |
0.51 |
|
| 1996 |
Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Research. 56: 1142-5. PMID 8640774 |
0.552 |
|
| 1995 |
Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genetics. 9: 439-43. PMID 7795652 DOI: 10.1038/Ng0495-439 |
0.38 |
|
| Show low-probability matches. |